Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

38 trials with published results (5%)

Research Maturity

295 completed trials (42% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.6%

39 terminated out of 701 trials

Success Rate

88.3%

+1.8% vs benchmark

Late-Stage Pipeline

6%

45 trials in Phase 3/4

Results Transparency

13%

38 of 295 completed with results

Key Signals

38 with results88% success39 terminated

Data Visualizations

Phase Distribution

377Total
Not Applicable (253)
Early P 1 (4)
P 1 (35)
P 2 (40)
P 3 (13)
P 4 (32)

Trial Status

Completed295
Unknown174
Recruiting107
Terminated39
Not Yet Recruiting30
Active Not Recruiting22

Trial Success Rate

88.3%

Benchmark: 86.5%

Based on 295 completed trials

Clinical Trials (701)

Showing 20 of 20 trials
NCT07456566Not ApplicableNot Yet RecruitingPrimary

Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease

NCT07012395Phase 2Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

NCT07431606Phase 2Not Yet RecruitingPrimary

Duloxetine in Inflammatory Bowel Diseases

NCT05753267Phase 2CompletedPrimary

Fenofibrate in Ulcerative Colitis

NCT04488471CompletedPrimary

Impact of Isolation in Patients With IBD During the COVID-19 Crisis

NCT03351972Phase 4Completed

Differences in Preparation for Small Bowel Capsule Endoscopy

NCT07555951Not ApplicableCompletedPrimary

Nurse Coaching on Symptom Management, Self-Care Activities, and Quality of Life in Individuals With Inflammatory Bowel Disease

NCT06286709Phase 2Recruiting

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

NCT06591013Not ApplicableCompletedPrimary

Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC

NCT05642247CompletedPrimary

Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science

NCT04225819Not ApplicableSuspended

Adjunctive Treatment With Vitamin D3 in Patients With Active IBD

NCT04923100CompletedPrimary

Therapeutic Effect of New Biologics in Crohn's Disease

NCT06094608Not ApplicableRecruitingPrimary

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

NCT05221281Not ApplicableActive Not RecruitingPrimary

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

NCT06315179RecruitingPrimary

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

NCT05653011RecruitingPrimary

Predictors of Prognosis in IBD Patients

NCT06910787Not ApplicableActive Not RecruitingPrimary

Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD)

NCT04647578Completed

Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis

NCT07352995Not ApplicableEnrolling By InvitationPrimary

Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe

NCT07539727RecruitingPrimary

Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study

Scroll to load more

Research Network

Activity Timeline